Sees FY24 adjusted EBITDA $39M-$51M.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HROW:
- Harrow Health options imply 17.9% move in share price post-earnings
- Harrow launches Vevye Access for All
- HROW Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- Harrow executes five-year supply, development agreement for Triesence
- Reddit initiated, Cigna downgraded: Wall Street’s top analyst calls